U.S. Luxury Stock News

In early February 2026, Performance Food Group reported higher quarterly and six‑month sales and earnings, modestly narrowed its full‑year 2026 net sales guidance to about US$67.25–68.25 billion, detailed no share repurchases under its latest authorization, and confirmed that it is actively pursuing acquisitions while refinancing its 2027 senior notes with new 2034 debt. The company’s explanation that profit pressure stemmed from higher‑than‑expected Cheney Brothers integration costs,...

Fastly (FSLY) has wrapped up FY 2025 with fourth quarter revenue of US$172.6 million and a basic EPS loss of US$0.10, setting the tone for another year where top line progress sits alongside ongoing red ink. The company has seen quarterly revenue move from US$140.6 million in Q4 2024 to US$172.6 million in Q4 2025, while basic EPS losses shifted from US$0.23 to US$0.10 over the same period. Over the trailing 12 months it generated US$624.0 million of revenue with a basic EPS loss of US$0.83...

NewMarket (NEU) has wrapped up FY 2025 with fourth quarter revenue of US$635.4 million and basic EPS of US$8.65, anchored by net income of US$81.3 million, alongside trailing twelve month revenue of US$2.7 billion and basic EPS of US$44.44. Over recent quarters, the company has seen revenue move from US$700.9 million and EPS of US$13.26 in Q1 2025 through to US$698.5 million and EPS of US$11.84 in Q2, US$690.3 million and EPS of US$10.67 in Q3, and then US$635.4 million and EPS of US$8.65 in...

If you are wondering whether LifeStance Health Group is attractively priced or still carrying a premium, you are not alone. This article is built to unpack what the current share price might be implying. The stock last closed at US$6.92, with a recent 7 day return of 5.8%, a 30 day return of 4.6% decline, and year to date and 1 year returns of 0.6% decline and 13.4% decline respectively, set against a 3 year return of 23.1%. Recent news coverage around LifeStance Health Group has focused on...

IPG Photonics (IPGP) has just posted its FY 2025 third quarter numbers, with revenue of US$250.8 million and basic EPS of US$0.18, as the market weighs what this means for the laser maker’s recent return to profitability. The company has seen quarterly revenue move from US$234.3 million in Q4 2024 to US$227.8 million in Q1 2025 and then to US$250.7 million and US$250.8 million in Q2 and Q3 2025. Basic EPS shifted from US$0.18 to US$0.09, US$0.16 and US$0.18 over the same stretch. That...

Belden's FY 2025 Earnings Snapshot Sets the Stage for Narrative Shifts Belden (BDC) just posted its FY 2025 third quarter numbers, with revenue of US$698.2 million and basic EPS of US$1.43, while trailing 12 month EPS came in at US$5.72 on revenue of US$2.7 billion. The company has seen revenue move from US$654.9 million in Q3 2024 to US$698.2 million in Q3 2025, with quarterly EPS shifting from US$1.32 to US$1.43 over the same periods, and trailing net income reaching US$228.0 million. With...

Hyatt Hotels (H) has just posted another loss making quarter, with Q3 FY 2025 revenue of US$883 million and basic EPS of a US$0.51 loss on net income excluding extra items of a US$49 million loss. The company has seen revenue move from US$761 million in Q4 FY 2024 to US$883 million in Q3 FY 2025, while quarterly EPS has shifted from a US$0.58 loss in Q4 FY 2024 to US$4.75 and US$3.55 profits in Q3 and Q2 FY 2024, then back to losses more recently. This presents a mixed picture on margins that...

If you are trying to figure out whether Excelerate Energy is priced attractively right now, it helps to step back and look at both the recent share moves and what they might be saying about expectations. The stock last closed at US$40.36, with returns of 12.7% over 7 days, 27.8% over 30 days, 42.4% year to date, and 36.9% over the past year. These moves may have changed how investors think about its potential and its risks. Recent news flow around Excelerate Energy has focused on its...

GCI Liberty (GLIB.A) has just posted a tough third quarter for FY 2025, with revenue of US$257 million alongside a basic EPS loss of US$13.34 and a net loss of US$387 million, setting a cautious tone around profitability. Over the past few quarters, the company has seen revenue move around the US$260 million mark, from US$262 million in Q3 2024 to US$266 million in Q1 2025 and US$261 million in Q2 2025. Basic EPS shifted from US$0.72 in Q3 2024 to US$1.22 in Q1 2025 and US$0.94 in Q2 2025...

Porch Group (PRCH) has wrapped up FY 2025 with Q4 revenue of US$124.3 million and a basic EPS loss of US$0.03, providing a clear snapshot of where the business stands on growth versus profitability. Over the past six reported quarters, revenue has moved from US$100.4 million in Q4 2024 to US$124.3 million in Q4 2025. Over the same period, quarterly EPS has ranged from a profit of US$0.30 to a loss of US$0.10, giving investors a mixed read on how much of that top line is flowing through to the...

Onity Group (ONIT) has just posted its latest FY 2025 results with Q3 revenue of US$280.3 million and EPS of US$2.20, set against a trailing twelve month earnings growth of 111% and a net profit margin that moved from 1.4% to 3.1%. Over recent quarters, the company has seen revenue move between US$246.4 million and US$280.3 million while quarterly EPS has ranged from a loss of US$3.63 in FY 2024 Q4 to US$2.72 in FY 2024 Q3 and US$2.20 in FY 2025 Q3. This gives investors a clearer view of how...

Iron Mountain (IRM) has put up another busy quarter, with Q3 FY 2025 revenue at US$1.75b and basic EPS of US$0.28, alongside funds from operations of US$198.31m and FFO per share of US$0.67. The company has seen revenue step from US$1.53b in Q2 FY 2024 to US$1.71b in Q2 FY 2025 and then to US$1.75b in Q3 FY 2025. EPS and FFO per share have moved between losses and profits over the same stretch as investors weigh the trade off between steady top line progress and mixed earnings prints. With...

PBF Energy (PBF) has opened FY 2025 with a sharp swing back into the black in the third quarter, reporting revenue of US$7.7b and EPS of US$1.47 on net income of US$170.1m. The company has seen quarterly revenue move from US$8.7b in Q2 2024 to US$7.1b in Q1 2025 and then to US$7.7b in Q3 2025, while EPS has ranged from a loss of US$3.53 in Q1 2025 to a modest loss of US$0.05 in Q2 2025 before returning to positive territory in Q3. This sets up a results season where margin reset and the route...

Howmet Aerospace FY 2025 Results in Focus Howmet Aerospace (HWM) has put solid numbers on the table for Q3 FY 2025, with revenue of US$2.1 billion and basic EPS of US$0.95, setting the tone for how the rest of the fiscal year is shaping up. The company has seen quarterly revenue move from US$1.88 billion in Q2 FY 2024 to US$2.09 billion in Q3 FY 2025, while basic EPS stepped from US$0.65 to US$0.95 over the same stretch, supported by trailing twelve month EPS of US$3.58. For investors, the...

If you are wondering whether Comstock Resources at around US$19.18 is offering good value or carrying more risk than reward, you are in the right place. The stock has seen mixed returns, with a 7 day return of 7.8% decline, a 30 day return of 14.2% decline, a year to date return of 18.7% decline, a 1 year return of 5.6%, a 3 year return of 53.4%, and a 5 year return that is a very large multiple of the starting point. Recent coverage around Comstock Resources has focused on its role in the...

LightPath Technologies (LPTH) just posted its latest quarterly update with Q2 2026 revenue of about US$15.1 million and a basic EPS loss of US$0.07, alongside trailing twelve month revenue of US$43.9 million and a basic EPS loss of US$0.39. Over recent periods the company has seen revenue move from US$8.6 million in Q4 2024 to US$12.2 million in Q4 2025. Quarterly EPS losses ranged between US$0.04 and US$0.16, which gives you a sense of how the top line has scaled against still pressured...

How CoreCivic’s FY 2025 Numbers Set the Stage for the Story Ahead CoreCivic (CXW) closed FY 2025 with fourth quarter revenue of US$604.0 million and basic EPS of US$0.26, while trailing twelve month revenue came in at about US$2.2 billion and EPS at US$1.09, framing a year where reported earnings grew 69.2% and five year average earnings growth was 33.1% per year. The company has seen revenue move from US$479.3 million in Q4 2024 to US$604.0 million in Q4 2025. Basic EPS over those quarters...

Sphere Entertainment (SPHR) has just posted its FY 2025 third quarter numbers, with revenue of US$262.5 million and a basic EPS loss of US$2.80, alongside a net income loss of US$101.2 million, setting a cautious tone around profitability. Over the past six reported quarters, revenue has moved between US$227.9 million and US$321.3 million, while basic EPS has ranged from a loss of US$2.95 to a gain of US$4.18, giving investors a mixed picture on earnings power. With trailing 12 month results...

Ford Motor (F) just posted a tough finish to FY 2025, with Q4 revenue of US$45.9 billion and a basic EPS loss of US$2.78, while trailing twelve month EPS came in at a loss of US$2.06 on revenue of US$187.3 billion. The company has seen quarterly revenue move from US$48.2 billion and EPS of US$0.46 in Q4 2024 to US$45.9 billion and a loss of US$2.78 per share in Q4 2025. Trailing EPS shifted from US$1.48 a year ago to a loss of US$2.06 most recently, setting up a results season where margins...

Antero Resources (AR) just wrapped up FY 2025 with Q4 results that included revenue of US$1.5b and basic EPS of US$0.63, while full year trailing figures showed total revenue of US$5.3b and EPS of US$2.05. Over the past year, revenue has moved from US$4.3b and EPS of US$0.18 on a trailing basis to US$5.3b and US$2.05, giving investors a much clearer earnings picture to weigh against the latest quarter’s US$193.7m in net income. With net profit margins reported at 12% over the last year versus...

H.C. Wainwright has initiated analyst coverage on Immunome, focusing on its oncology pipeline and overall positioning. The coverage launch brings additional attention to Immunome’s approach to cancer therapeutics and its progress as a NasdaqCM:IMNM listed company. Immunome, trading on NasdaqCM:IMNM, last closed at $22.425, with a 1 year return of 115.0% and a 3 year return that is roughly 4x. Over the past 30 days, the stock shows an 11.3% return, while the 7 day return reflects a 6.6%...

Nabors Industries (NBR) has just posted a sharp swing in its FY 2025 third quarter results, with revenue at US$818.2 million and Basic EPS of US$18.25, alongside trailing 12 month Basic EPS of US$15.31 supported by a one off gain of US$449.0 million and net income of US$183.2 million. The company has seen quarterly revenue move from US$734.8 million in Q2 2024 to US$832.8 million in Q2 2025, while quarterly Basic EPS ranged from a loss of US$6.86 in Q3 2024 to a profit of US$18.25 in Q3 2025...

Leggett & Platt (LEG) closed out FY 2025 with Q4 revenue of US$938.6 million and basic EPS of US$0.18. On a trailing twelve month basis, the company generated US$4.1 billion of revenue and EPS of US$1.70 as it moved back into positive net income of US$235.4 million. Over recent quarters, revenue has ranged from US$1.1 billion in Q2 2025 to US$938.6 million in Q4 2025. Quarterly EPS moved from US$0.10 in Q4 2024 to US$0.92 in Q3 2025 before landing at US$0.18 in the latest quarter, giving...

Ascendis Pharma (NasdaqGS:ASND) has just posted its FY 2025 third quarter numbers, reporting revenue of €213.6 million and a basic EPS loss of €1.00. Net income excluding extra items came in at a loss of €61.0 million, keeping the focus firmly on how the business is scaling its top line against ongoing losses. Over the past few quarters, the company has reported revenue of €57.8 million in Q3 2024, €100.9 million in Q1 2025, €158.0 million in Q2 2025 and now €213.6 million in Q3 2025. Over...